Business Wire

Celonis Named a Leader in Process Intelligence Software

Share

Celonis, a global leader in Process Mining, today announced it has been named a Leader in The Forrester Wave™: Process Intelligence Software, Q3 2025.

According to the report, “Celonis is best suited to clients looking for a sophisticated platform that supports enterprise-wide process intelligence and control to transform operations.” Forrester also cited Celonis’ trailblazing role in the category, noting its early adoption of graph databases, an additional object-centric view of process performance, and an extended marketplace of partner-built solutions.

“We are honored to be named a Leader in The Forrester Wave: Process Intelligence. This recognition is only possible because of the dedication and commitment of our customers, partners and Celonauts,” said Carsten Thoma, President and Board Director, Celonis. “Enterprise AI is set to reinvent operations. To deliver on its full potential, AI needs to understand how each business runs and how to make it run better. Our Process Intelligence platform uniquely empowers customers to drive continuous operational improvement, implement effective AI solutions, and deliver measurable business outcomes.”

Our highlights from the Forrester Evaluation:

  • Highest scores possible in innovation, vision, and roadmap criteria: Forrester praised Celonis for maintaining a “trailblazing role” in the market, with clear investments in AI and automation.
  • AI embedded across the platform: Generative AI capabilities are integrated throughout, from a data annotation builder to a Process Copilot.
  • High customer feedback: Customers cited the platform’s sophistication and flexibility, while also praising features that orchestrate processes and use AI.

The report evaluated 15 vendors across 25 criteria, grouped by current offering, strategy, and customer feedback. Celonis received the highest scores possible across 18 criteria, including analytics and digital twins.

To access report visit The Forrester Wave™: Process Intelligence Software, Q3 2025

About Celonis

Celonis makes processes work for people, companies and the planet. The Celonis Process Intelligence Platform uses industry-leading process mining and AI technology and augments it with business context to give customers a living digital twin of their business operation. It’s system-agnostic and without bias, and provides everyone with a common language for understanding and improving businesses. Celonis enables its customers to continuously realize significant value across the top, bottom, and green line.

Celonis is headquartered in Munich, Germany, and New York City, USA, with more than 20 offices worldwide.

© 2025 Celonis SE. All rights reserved. Celonis and the Celonis “droplet” logo are trademarks or registered trademarks of Celonis SE in Germany and other jurisdictions. All other product and company names are trademarks or registered trademarks of their respective owners.

Forrester does not endorse any company, product, brand, or service included in its research publications and does not advise any person to select the products or services of any company or brand based on the ratings included in such publications. Information is based on the best available resources. Opinions reflect judgment at the time and are subject to change. For more information, read about Forrester’s objectivity here.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250812570502/en/

Contacts

Media Contact
press@celonis.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

StatLab Empowers Growth in Key European Countries through Direct Market Expansions in Germany and France13.8.2025 17:26:00 EEST | Press release

StatLab Medical Products (“StatLab”), a leading global developer and manufacturer of medical diagnostic supplies and equipment, today announced the completed acquisitions of Germany-based histology service and distribution company Histoserve GmbH (“Histoserve”) as well as Diapath France SAS (“Diapath France”). These moves mark a significant step forward in StatLab’s European growth strategy, expanding its direct commercial presence to the top four European markets: France, Germany, Italy, and the UK, a milestone that positions StatLab among the few suppliers with fully direct access to Europe’s largest pathology markets, enabling closer customer relationships and expanded access to StatLab’s full product portfolio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250813235270/en/ Founded by Wolfgang Jakobi in 2010 near Hannover, Germany, Histoserve has evolved into a comprehensive solutions provider for pathology labs, providi

BM3EAC Corp. 2025 Semi-Annual Report13.8.2025 16:38:00 EEST | Press release

BM3EAC Corp. (the “Company”), a special purpose acquisition company incorporated under the laws of the Cayman Islands as an exempted company with limited liability and listed on Euronext Amsterdam, the regulated market operated by Euronext Amsterdam N.V., today published its semi-annual report for the period 1 January 2025 to 30 June 2025. The semi-annual report can be downloaded from the Company’s website via the following link: https://www.BrigadeM3EAC.com/documents IMPORTANT INFORMATION This press release contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. DISCLAIMER The Company’s semi-annual report referenced in this announcement may include forward-looking statements, which are based on the Company's current expectations and projections regarding a business combination, the business, the economy and other future conditions of the Company and speak only as of the date hereof. Forward-looking statements may

Andersen Consulting Expands Platform with Alamo Consultores13.8.2025 16:30:00 EEST | Press release

Andersen Consulting expands its technology transformation capabilities through a Collaboration Agreement with Alamo Consultores. Established in Argentina since 2012, Alamo Consultores is a boutique consulting firm delivering customized technology solutions to clients across Latin America, North America, and Europe. The firm provides end-to-end support across the SAP lifecycle, including implementation, upgrades, and ongoing management, to clients in the retail, manufacturing, finance, logistics, energy, healthcare, and automotive industries. Alamo Consultores’ service offerings span functional and technical consulting, system migrations, sustainability consulting, digital transformation, and outsourcing. “At Alamo Consultores, we focus on turning complexity into clarity, enabling clients to evolve through technology with flexibility, integrity, and long-term vision,” said Pablo Villamil, founder and CEO. “Becoming a collaborating firm of Andersen Consulting allows us to expand our reac

INSERTING and REPLACING SBC Medical Group Holdings Announces Second Quarter 2025 Financial Results13.8.2025 16:15:00 EEST | Press release

Insert after the second paragraph, 9th bullet: First Half 2025 Highlights. The updated release reads: SBC MEDICAL GROUP HOLDINGS ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS SBC Medical Group Holdings Incorporated (NASDAQ: SBC, “SBC Medical” or the “Company”), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced its financial results for the second quarter of fiscal year 2025 (three months ended June 30, 2025) and for the first half of fiscal year 2025 (six months ended June 30, 2025). Second Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $15 million, representing a 47% year-over-year decrease. Net Income attributable to SBC Medical Group was $2.5 million, representing an 87% year-over-year decrease. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shar

Amazfit Partners With Female Elite Trail Runners Ruth Croft and Rosa Lara Feliu to Drive Innovation in Sports Watches13.8.2025 16:00:00 EEST | Press release

Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), today announced a landmark partnership with Ruth Croft, one of the most accomplished trail and ultra runners in the world. The brand also welcomes Rosa Lara Feliu, a fast-rising Spanish mountain runner, to its growing global performance team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250813966185/en/ Amazfit Partners with female Elite Trail Runners Ruth Croft and Rosa Lara Feliu to Drive Innovation in Sports Watches Croft, born and raised in New Zealand, has spent more than a decade at the pinnacle of the sport. Her career includes prestigious wins at the Golden Trail World Series, Mont Blanc Marathon, OCC by UTMB, and Les Templiers, as well as top finishes at the sport’s most competitive ultras. Since stepping up to the ultra distance in 2020, she has claimed victories at Western States Endurance Run 100 miles, Tarawera 100K, and CCC by

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye